{"id":17912,"date":"2018-12-10T14:23:53","date_gmt":"2018-12-10T13:23:53","guid":{"rendered":"https:\/\/www.criep.eu\/gamba-s-2016-the-effect-of-intellectual-property-rights-on-domestic-innovation-in-the-pharmaceutical-sector-cesifo-working-paper-series-no-6004\/"},"modified":"2018-12-10T14:23:53","modified_gmt":"2018-12-10T13:23:53","slug":"gamba-s-2016-the-effect-of-intellectual-property-rights-on-domestic-innovation-in-the-pharmaceutical-sector-cesifo-working-paper-series-no-6004","status":"publish","type":"post","link":"https:\/\/www.criep.eu\/en\/gamba-s-2016-the-effect-of-intellectual-property-rights-on-domestic-innovation-in-the-pharmaceutical-sector-cesifo-working-paper-series-no-6004\/","title":{"rendered":"Gamba S. (2016). The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector. CESifo Working Paper Series No. 6004."},"content":{"rendered":"

[vc_row 0=””][vc_column 0=””][vc_column_text 0=””]<\/p>\n

Gamba S. (2016).<\/p>\n

The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector. CESifo Working Paper Series No. 6004. <\/a><\/em><\/p>\n

 <\/p>\n

Abstract:<\/p>\n

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for their distribution, count data models are used. A Zero Inated Negative Binomial model is adopted to consider the choice not to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries is roughly half of that for developed countries.<\/em><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row 0=””][vc_column 0=””][vc_column_text 0=””] Gamba S. (2016). The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector. CESifo Working Paper Series No.…<\/p>\n","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[725],"tags":[665,465,462,668,466,464,670,467],"coauthors":[929],"class_list":["post-17912","post","type-post","status-publish","format-standard","hentry","category-working-papers-en","tag-developing-countries-en","tag-innovation","tag-intellectual-property-rights","tag-patents-en","tag-patents","tag-pharmaceutical-sector","tag-trips-en","tag-trips","category-725","description-off"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t